[Risk factors and short-term prognosis of early pulmonary hypertension in preterm infants]

C H Wang1, J J Chen1, J J Ge1

  • 1Department of Neonatal Intensive Care Unit, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.

Insights

Early pulmonary hypertension (PH) in preterm infants is linked to prolonged rupture of membranes, small for gestational age, low Apgar scores, respiratory distress syndrome, and patent ductus arteriosus. This condition increases mortality and the risk of bronchopulmonary dysplasia.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Respiratory Medicine

Background:

  • Pulmonary hypertension (PH) is a serious complication in preterm infants.
  • Identifying risk factors and prognosis for early PH is crucial for timely intervention.
  • Preterm infants (<32 weeks gestation) are particularly vulnerable to developing PH.

Purpose of the Study:

  • To investigate the risk factors associated with early pulmonary hypertension (PH) in preterm infants.
  • To evaluate the short-term prognosis of preterm infants diagnosed with early PH.
  • To identify independent predictive factors for the development of early PH.

Main Methods:

  • Retrospective case-control study involving preterm infants (<32 weeks gestation).
  • Matched 80 preterm infants with early PH (3-14 days) to 160 controls.
  • Analyzed perinatal records, complications, echocardiography, and early outcomes using logistic regression.

Main Results:

  • Independent predictors for early PH included prolonged rupture of membranes (>1 week), small for gestational age (SGA), 5-min Apgar score ≤7, neonatal respiratory distress syndrome (RDS), and hemodynamically significant patent ductus arteriosus (hsPDA).
  • Infants with early PH exhibited higher rates of bronchopulmonary dysplasia (BPD), BPD-associated PH, severe intraventricular hemorrhage (IVH), extrauterine growth retardation (EUGR), retinopathy of prematurity (ROP) requiring laser treatment, and mortality.
  • The duration of invasive mechanical ventilation was significantly longer in the early PH group.

Conclusions:

  • Preterm infants with prolonged rupture of membranes, SGA, low Apgar scores, RDS, and hsPDA face an increased risk of developing early PH.
  • Early PH is associated with significantly worse short-term outcomes, including higher mortality and increased incidence of major neonatal morbidities.
  • These findings highlight the importance of monitoring and managing these risk factors in high-risk preterm infants.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
280
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
33
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
315
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
325